Should all postmenopausal patients with hormone receptor-positive breast cancer receive initial therapy with aromatase inhibitors?

Author(s):: Aapro, M.; Velde, C.J.H. van de (0000-0003-0104-1800); Markopoulos, C.; Bartlett, J.M.S.; Putter, H.; Coleman, R.E.

Published: 2013
Publication type: Article / Letter to editor

PostmenopausalBreast cancerAromatase inhibitors

Date issued: 2013-08-31
Language: English
Is part of: The Breast (2013), Vol. 22, no. 4, p. 488-494
hdl: 1887/101629
doi: 10.1016/j.breast.2013.01.007